Mitsu Chem Plast Ltd
P&L
Quarterly Standalone
vs Q3 FY26
Mitsu Chem Plast: Net Profit Jumps 117.91% in Q4FY26
02 May 2026 · 2 May, 9:41 pm
Summary
Mitsu Chem Plast Limited reported an impressive financial performance for both Q4 FY26 and the full fiscal year FY26. The company's Net Profit in Q4 FY26 saw a significant jump of 117.91% year-over-year to ₹771.73 crore, while full-year FY26 Net Profit increased by 115.40% to ₹1561.87 crore. EBITDA also demonstrated robust growth, rising by 72.98% in Q4 FY26 to ₹1422.74 crore, leading to substantial margin expansion. Chairman Mr. Jagdish Dedhia attributed this performance to disciplined execution, better operating efficiencies, and a focus on higher value-added products, highlighting strong scaling in the Furnastra healthcare vertical, a robust export business, and a strategic entry into the Intermediate Bulk Container vertical.
Key Highlights
- 1
Mitsu Chem Plast Limited's Net Profit for Q4 FY26 surged by 117.91% year-over-year to ₹771.73 crore.
- 2
For the full fiscal year FY26, Net Profit increased by 115.40% year-over-year, reaching ₹1561.87 crore.
- 3
EBITDA for Q4 FY26 grew by 72.98% to ₹1422.74 crore, with the EBITDA margin expanding by 736 basis points to 16.45%.
- 4
Total Income for the full FY26 was ₹35084.56 crore, representing a 5.40% year-over-year increase.
- 5
The company expanded its operational capacity by ~900 MT per annum, bringing total installed capacity to ~29,900+ MT, with Unit 4 at Boisar commencing operations in January 2026.
- 6
Mitsu Chem Plast entered into a Global Supplier Agreement with Arjohuntleigh Polska (Poland), enhancing its global presence and export opportunities in the healthcare vertical.
- 7
The company also made a strategic entry into the Intermediate Bulk Container vertical, identified by management as a significant new avenue for growth.
Management Comments
Jagdish Dedhia
Q4 FY26 has been a satisfying close to what has been a year of steady and purposeful progress for Mitsu Chem Plast. We delivered meaningful improvement in profitability during the quarter, driven by disciplined execution, better operating efficiencies, and a continued focus on higher value-added products. Our Furnastra healthcare furniture vertical continues to scale well, and our export business remains on a strong growth trajectory spanning more than 17 countries. We are also excited about our strategic entry into the Intermediate Bulk Container vertical, which we believe is a natural and well-timed extension of our packaging capabilities and will open a significant new avenue for growth. As we step into FY27, we remain committed to disciplined capital deployment, operational excellence, and delivering sustainable long-term value for all our stakeholders.
Informational and educational content only. Not investment advice.